LEIDEN JEFFREY M
30 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Tax withholding | 17 | $18.00 | $306.00 | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 28,698 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Option exercise | 2,963 | — | — | filing |
| 2026-05-08 | ODTX | Odyssey Therapeutics, Inc. | Buy | 5,000 | $20.00 | $100,000.00 | filing |
| 2026-02-24 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 3,547 | $485.11 | $1.7M | filing |
| 2026-02-18 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Tax withholding | 2,964 | $483.75 | $1.4M | filing |
| 2026-02-17 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 8,269 | $0.00 | $0.00 | filing |
| 2026-01-22 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Award | 9,012 | $0.00 | $0.00 | filing |
| 2025-12-04 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Option exercise | 1 | $91.05 | $91.05 | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 15,681 | $452.20 | $7.1M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Option exercise | 63,781 | $86.52 | $5.5M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 10,360 | $453.34 | $4.7M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 7,899 | $445.56 | $3.5M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 5,880 | $449.84 | $2.6M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 5,809 | $451.20 | $2.6M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 4,469 | $440.40 | $2.0M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 4,352 | $444.36 | $1.9M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,469 | $443.21 | $1.1M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,320 | $448.78 | $1.0M | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 2,070 | $455.22 | $942,305.40 | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,320 | $441.26 | $582,463.20 | filing |
| 2025-12-03 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,152 | $447.05 | $515,001.60 | filing |
| 2025-11-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 32,234 | $440.30 | $14.2M | filing |
| 2025-11-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 21,330 | $441.35 | $9.4M | filing |
| 2025-11-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Option exercise | 39,769 | $86.52 | $3.4M | filing |
| 2025-11-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Option exercise | 13,835 | $91.05 | $1.3M | filing |
| 2025-11-14 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 40 | $442.00 | $17,680.00 | filing |
| 2025-11-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 18,528 | $440.22 | $8.2M | filing |
| 2025-11-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Option exercise | 19,688 | $91.05 | $1.8M | filing |
| 2025-11-13 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Sale | 1,160 | $441.05 | $511,618.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.